Increasing evidence highlights that microRNAs (miRNAs) drive glioma initiation and development. Nevertheless, the underlying role of miR-21-5p in glioma is elusive. Hence, we evaluated the underlying role of miR-21-5p in glioma progression. Microarray data analysis provided data indicating that the miR-21-5p level was elevated in glioma. Silenced miR-21-5p suppressed glioma cell growth and invasion. Additionally, our results disclosed that ten-eleven translocation 1 (TET1) was directly targeted by miR-21-5p. Furthermore, antagomir-21-5p restrained glioma cell growth in a xenograft tumour model. In rescue experiments, knockdown of TET1 neutralized miR-21-5p silence-mediated inhibitory function on glioma cell aggressiveness. Taken together, miR-21-5p exerted its carcinogenic effect in glioma cell growth and invasin by targeting TET1.
Background Alzheimer's disease (AD) is the leading cause of dementia, yet its underlying causes remain unknown. Increasing evidence supports a role for epigenetic modifications in AD pathogenesis. N6-methyladenosine (m6A), the most common RNA modification, is critical for learning and memory, and its abnormal presence has been observed in the brains of AD patients and animal models. Methods To compare levels of m6A in RNA as well as expression of the responsible enzymes in peripheral blood mononuclear cells (PBMCs) between AD patients and healthy controls. 42 AD patients and 42 age-matched healthy controls were prospectively enrolled from the Affiliated Hospital of Jining Medical University. m6A levels in RNA were quantified and expressions of m6A-related proteins and mRNA were examined. Genome-wide profiling of m6A-tagged transcripts was performed by m6A-modified RNA immunoprecipitation sequencing and RNA sequencing. Results Lower levels of m6A in PBMCs RNA in AD patients compared to controls, as well as downregulation of m6A methyltransferase and demethylase components. Dysregulation of m6A was associated with upregulation of m6A at 230 loci and downregulation at 163 loci, resulting in altered expression of disease-related genes. Conclusion Dysregulation of m6A in RNA may play a role in AD pathogenesis and may provide new avenues for diagnosis and treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.